Photodiagnosis and treatment of condyloma acuminatum using 5-aminolevulinic acid and homemade devices

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 1, 2012, Pages 60-68

  Inada, Natalia Mayumi ^a   da Costa, Mardoqueu Martins ^a   Guimarães, Orlando C C ^a   da Silva Ribeiro, Elizeu ^a   Kurachi, Cristina ^a   Quintana, Silvana Maria ^a   Lombardi, Wellington ^b   Bagnato, Vanderlei Salvador ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Universitario de Araraquara   (Brazil)

Author keywords

Condyloma; Homemade device; Human papillomavirus; Photodiagnosis; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADOLESCENT; ADULT; ARTICLE; BLEACHING; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; ILLUMINATION; MEDICAL DEVICE; PAIN; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; WART VIRUS;

ADOLESCENT; ADULT; AGED; AMINOLEVULINIC ACID; CONDYLOMATA ACUMINATA; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84857503740     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.09.001     Document Type: Article

References (29)

1. Howell-Jones R., Bailey A., Beddows S., et al. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 2010, 103(2):209-216. 10.1038/sj.bjc.6605747.
2. Kodner C.M., Nasraty S. Management of genital warts. Am Fam Physician 2004, 70(12):2335-2342.
3. Crosbie E.J., Brabin L. Cervical cancer: problem solved? Vaccinating girls against human papillomavirus. BJOG 2010, 117(2):137-142.
4. Fehr M.K., Chapman C.F., Krasieva T., et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after application of 5-aminolevulinic acid. Am J Obstst Gynecol 1996, 174(3):951-957. 10.1016/S0002-9378(96)70332-0.
5. Martin-Hirsch P.L., Whitehurst C., Buckley C.H., Moore J.V., Kitchener H.C. Photodynamic treatment for lower genital tract intraepithelial neoplasia. The Lancet 1998, 351(9113):1403. 10.1016/S0140-6736(98)24019-0.
6. Hillemanns P., Untch M., Pröve F., Baumgartner R., Hillemanns M., Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999, 93(1):71-74.
7. Bosch F.X., Manos M.M., Muñoz N., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87(11):796-802.
8. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
9. Franco E., Villa L., Rohan T., Ferenczy A., Petzl-Erler M., Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica 1999, 6(4):223-233.
10. Trottier H., Mahmud S., Costa M.C., et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006, 15(7):1274-1280. 10.1158/1055-9965.EPI-06-0129.
11. Sasagawa T., Basha W., Yamazaki H., Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001, 10(1):45-52.
12. Simen-Kapeu A., Kataja V., Yliskoski M., et al. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis 2008, 40(9):745-751. 10.1080/00365540801995360.
13. Andersen B.L., Turnquist D., LaPolla J., Turner D. Sexual functioning after treatment of in situ vulvar cancer: preliminary report. Obstet Gynecol 1998, 71(1):15-19.
14. Herod J.J., Shafi M.I., Rollason T.P., Jordan J.A., Luesley D.M. Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women. Br J Obstet Gynaecol 1996, 103(5):446-452.
15. Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990, 6(1-2):143-148. 10.1016/1011-1344(90)85083-9.
16. Henderson B., Dougherty T. How does photodynamic therapy work?. Photochem Photobiol 1992, 55(1):145-157. 10.1111/j.1751-1097.1992.tb04222.x.
17. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992, 14(4):275-292.
18. Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997, 79(12):2282-2308. 10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O.
19. Cottrell W.J., Paquette A.D., Keymel K.R., Foster T.H., Oseroff A.R. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008, 14(14):4475-4483. 10.1158/1078-0432.CCR-07-5199.
20. Liu H.F., Xu S.Z., Zhang C.R. Influence of CaNa2 EDTA on topical 5-aminolaevulinic acid photodynamic therapy. Chin Med J (Engl) 2004, 117(6):922-926.
21. Casas A., Fukuda H., Di Venosa G., Batlle A.M. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br J Dermatol 2000, 143(3):564-572. 10.1111/j.1365-2133.2000.03711.x.
22. Wiegell S.R., Stender I.M., Na R., Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003, 139(9):1173-1177.
23. Rud E., Gederaas O., Høgset A., Berg K. 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000, 71(5):640-647. 10.1562/0031-8655(2000)0710640AABNAA2.0.CO2.
24. Warren C.B., Karai L.J., Vidimos A., Maytin E.V. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol 2009, 61(6):1033-1043. 10.1016/j.jaad.2009.03.048.
25. Wiegell S.R., Skiveren J., Philipsen P.A., Wulf H.C. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008, 158(4):727-733. 10.1111/j.1365-2133.2008.08451.x.
26. Wiegell S.R., Haedersdal M., Wulf H.C. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009, 89(2):145-149. 10.2340/00015555-0568.
27. Frisch M., Fenger C., van den Brule A.J., et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999, 59(3):753-757.
28. Nucci V., Torchia D., Cappugi P. Treatment of anogenital condylomata acuminata with topical photodynamic therapy: report of 14 cases and review. Int J Infect Dis 2010, 14S:e280-e282.
29. Wang H.W., Wang X.L., Zhang L.L., Guo M.X., Huang Z. Aminolevulinic acid (ALA)-assisted photodynamic diagnosis of subclinical and latent HPV infection of external genital region. Photodiagnosis Photodyn Ther 2008, 5(4):251-255.